Mycosis fungoides (MF) and Sézary syndrome (SS) comprise approximately 53% of
cutaneous lymphomas. Both MF and SS may clinically and histologically mimic benign skin …

Primary cutaneous lymphomas are currently classified by the European Organization for
Research and Treatment of Cancer (EORTC) classification or the World Health Organization …

Mycosis fungoides (MF) and Sézary syndrome (SS), the major forms of cutaneous T-cell
lymphoma, have unique characteristics that distinguish them from other types of non …

The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group
classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions …

Purpose To evaluate the activity and safety of the histone deacetylase inhibitor vorinostat
(suberoylanilide hydroxamic acid) in persistent, progressive, or recurrent mycosis fungoides …

The activity and safety of the histone deacetylase inhibitor vorinostat (suberoylanilide
hydroxamic acid, SAHA) were evaluated in patients with refractory cutaneous T-cell …

Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Objectives To study and update the clinical characteristics and long-term outcome of our
patients with mycosis fungoides (MF) and Sézary syndrome (SS), and to identify important …

Abstract Disease Overview Cutaneous T‐cell lymphomas (CTCL) are a heterogenous group
of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative
disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and …